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Malaria is by far the most important tropical parasitic disease worldwide and is responsible each year for 
more than 300 million acute illnesses and at least one million deaths. The disease that was previously 
controlled or even eradicated in more than one hundred countries located in the intertropical belt is now re-
emerging in these areas, especially due to the resistance of anopheles against the means used for fighting 
vector-borne diseases. Adding the poor quality and the many counterfeits of the antimalarial drugs available 
on the Congolese pharmaceutical market, the country is facing a major public health problem which 
explains the interest in a LC control method for different trademarked drugs. Currently, the health policy, 
recommended by WHO is based on ACTs (Artemisinin-based combination therapy) [1]. For the 
development of the conventional LC method, a multivariate design of experiment strategy coupled to Design 
Space approach was used [2]. This preliminary study was focused on the following common antimalarial 
drugs: amodiaquine, atovaquone, chloroquine, cinchonine, lumefantrine, mefloquine, primaquine, proguanil, 
pyrimethamine, quinine, sulfadoxine and sulfalene, and 4 conservatives: methylparaben, propylparaben, 
butylhydroxyanisole and butylhydroxytoluene. The present study presents the results of a geometrical 
transfer [3] of this generic LC method – able to track multiple antimalarial drugs having as objective the 
detection of forgery or counterfeit of these medicines – to UHPLC. In addition, UHPLC was compared to 
conventional HPLC in terms of separation quality, separation speed, data processing time and data quality. 
To do so, two types of transfer methods were carried out: the first allow the same separating power as the 
existing HPLC method for a significant shorter analysis time (Figure (a)) and the second kept the same 
analysis time for a much greater separating efficiency (Figure (b)). To summarize, both methods present 
high quality data and low reagent consumption, therefore low production of organic waste, and the first one 
also combined an extremely fast turnaround time. 
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